Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
PT-141 was FDA-approved in 2019 under the brand name Vyleesi for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women, representing the first melanocortin receptor agonist approved for this indication
To begin your Dihexa treatment, schedule a consultation with our experienced wellness specialists at AlluraMD
The page leans into safety and side-effect planning and the details behind side effects, provider access, safety and pharmacy quality
For more information Visit Store or Download Brochure
The 3.0 mL dilution keeps each dose at 18 units or more, where U-100 syringe markings are most precise
US$ 25.60
US$ 29.86
US$ 22.13
US$ 21.90
US$ 24.21
